Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
mkt cap is still only 68mm, no reason this couldnt be a 500mm company
what is not to love - straight from 60 to 70 today ... dollar soon?
I love the action so far!
been in this thing over 3 years.. was accumulating tons down in the 20 and 30 c range... this thing could get over $5 IMHO it's been past that before!!
I'm in @ $TRXC Hope it's a good ride!
Some volume is happening and I have in the corner of my eye
Making money? Lol, For the three months ended September revenue was 750K.
For the three months ended September 30, 2020, net loss attributable to common stockholders was $15.1 million, or $0.15 per share.
TransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 5, 2020 https://stocknewsnow.com/companynews/5717081229141006/TRXC/101843
52-Wk Range 0.28 - 6.31 https://transenterix.com/
Spk!! Where do we go next
JUST IN: $TRXC TransEnterix Announces First Pediatric Surgical Cases with Senhance® Surgical System
Pediatric Patients Successfully Treated Utilizing 3mm Instruments on Digital Laparoscopy Platform TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, tod...
Find out more TRXC - TransEnterix Announces First Pediatric Surgical Cases with Senhance® Surgical System
* * $TRXC Video Chart 10-13-2020 * *
Link to Video - click here to watch the technical chart video
Im not seeing the fire in this
Why is it down in the pre-market today?
* * $TRXC Video Chart 10-07-2020 * *
Link to Video - click here to watch the technical chart video
Let’s not forget there can be more than one winner. Let’s take Uber and Lyft example Uber completely copied Lyft which paved the way for ride-sharing. Just like as were seeing here.
JUST IN: $TRXC TransEnterix Announces Toshima Hospital in Japan to Initiate a Senhance® Digital Laparoscopy Program
Japan is One of the Fastest Growing Markets for Senhance Surgical System TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Tos...
Read the whole news TRXC - TransEnterix Announces Toshima Hospital in Japan to Initiate a Senhance® Digital Laparoscopy Program
WE MAY HAVE ANOTHER $ISRG (Intuitive Surgical) IN THE MAKING.....TIME TO LOAD UP WHILE IT'S STILL VERY UNDERVALUED
NEWS: $TRXC TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities
Intelligent Surgical Unit Enables Augmented Intelligence on the Senhance System TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that ...
In case you are interested TRXC - TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities
* * $TRXC Video Chart 09-23-2020 * *
Link to Video - click here to watch the technical chart video
HUUUUGE NEWS OUT, GREAT FIND. BARGAIN BASEMENT PRICE HERE WITH FANTASTIC PRICE POTENTIAL, ESPECIALLY CONSIDERING THE 52 WK HIGH OF $10.00
TransEnterix Ushers in New Era of Robotic Surgery with First Usage of Machine Vision Capabilities
Intelligent Surgical Unit Enables Augmented Intelligence on the Senhance System
September 23, 2020 06:55 AM Eastern Daylight Time
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Hackensack Meridian Health Pascack Valley Medical Center, a hospital in New Jersey, successfully completed its first surgical procedures using the Intelligent Surgical UnitTM (ISU™). The technology previously received FDA clearance, and currently enables machine vision capabilities on the Senhance? Surgical System. The patients were treated by Dr. Amit Trivedi, Chair of Surgery at Hackensack Meridian Health Pascack Valley Medical Center, and his team in multiple general surgery procedures.
https://www.businesswire.com/news/home/20200923005174/en/TransEnterix-Ushers-in-New-Era-of-Robotic-Surgery-with-First-Usage-of-Machine-Vision-Capabilities
Keeping an eye on this one...have been for years actually. $TRXC
Was hoping someone could help me with something. Why does Transenterix have approvals for 4 arms in Europe and they only sought approval for 3 arms for FDA?
German NEWS?? lol...
I went to the TRXC website, the last time they posted news was January 2020...no wonder we lack investment interest.
I don't think I'm staying in this one very long. It was a swing trade to start...hope we can all meet our goals.
This dog may be having a day...let's hope for more...any German news??
Thanks for the info/reply. Good luck to you.
There was some kind of news for the German market not carried here.
On June 3rd/4th: Why did the stock go from .40 to .80 ? Was there some kind of FDA approval? There is no news I can find in that time period? Thanks.
Best by 44%
TransEnterix Announces Submission of General Surgery Expansion in the US
6:55 AM ET 8/4/20 | BusinessWire
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--August 04, 2020--
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has submitted an indications filing to the FDA to expand General Surgery usage of the Senhance Surgical System.
"This submission is an important milestone for the continued application of Senhance in the highest volume and value procedures," said Anthony Fernando, president and chief executive officer at TransEnterix. "General Surgery is by far the largest procedural area in minimally invasive abdominal surgery, and we are pleased to have submitted significant additional clinical data to expand the procedures for which surgeons can utilize the benefit of Senhance."
The Senhance System is the first and only digital laparoscopic surgical platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including, 3 mm mini-laparoscopic instruments, eye sensing camera control and reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy. The Senhance System is also the first machine-vision system in robotic surgery which is powered by the new intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery.
Current Senhance US Indication for Use
The Senhance(R) Surgical System is intended to assist in the accurate control of laparoscopic instruments for visualization and endoscopic manipulation of tissue including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, mobilization and retraction. The Senhance Surgical System is intended for use in laparoscopic gynecological surgery, colorectal surgery, cholecystectomy, and inguinal hernia repair. The system is indicated for adult use. It is intended for use by trained physicians in an operating room environment in accordance with the Instructions for Use.
About TransEnterix
At TransEnterix, Inc., we are digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through a new category of care called Digital Laparoscopy. Digitizing the interface enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and allows us to address the current clinical, cognitive and economic shortcomings in surgery. The system features the first machine vision system for use in robotic surgery which is powered by the new intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery. The Senhance(R) Surgical System brings the benefits of Digital Laparoscopy to patients around the world while staying true to the principles of value-based healthcare. Learn more about Digital Laparoscopy with the Senhance Surgical System here: https://Senhance.com/. Now available for sale in the US, the EU, Japan, and select other countries. For a complete list of indications for use, please visit: https://www.transenterix.com/indications-for-use/.
Forward-Looking Statements
This press release includes statements relating to the Senhance System and the Company's submission of an indication filing to the FDA to expand General Surgery usage of the Senhance Surgical System. These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and include whether the FDA will clear the filing to expand the General Surgery indication usage of the Senhance Surgical System. For a discussion of the risks and uncertainties associated with TransEnterix's business, please review our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 16, 2020 and our other filings we make with the SEC. You are cautioned not to place undue reliance on these forward looking statements, which are based on our expectations as of the date of this press release and speak only as of the origination date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200804005239/en/
CONTACT: For TransEnterix, Inc.
Investor Contact:
Mark Klausner, +1 443-213-0501
invest@transenterix.com
or
Media Contact:
Terri Clevenger, +1 203-682-8297
terri.clevenger@icrinc.com
SOURCE: TransEnterix, Inc.
Copyright Business Wire 2020
> Dow Jones Newswires
August 04, 2020 06:55 ET (10:55 GMT)
Pump it up for the 10 to 14 cent pushes when is it really gonna move
What backwards again do you have a target price 4 days in a row I got in on and it went down
Shortie pays now or in the morning... JMO
* * $TRXC Video Chart 07-30-2020 * *
Link to Video - click here to watch the technical chart video
Followers
|
180
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
7900
|
Created
|
10/20/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |